View this email in your browser ([link removed])
[link removed] July 8, 2025
** IAS 2025 Conference: What you need to know
------------------------------------------------------------
Dear Advocate,
IAS 2025, the 13th International AIDS Society ([link removed]) (IAS) Conference on HIV Science will be held next week, July 13 – 17 in Kigali, Rwanda. IAS 2025 comes at a defining moment. Scientific advances in prevention, treatment and potential avenues for a cure, are within reach, but global funding cuts are placing these innovations and their scientific discovery at risk. All this is jeopardizing the gains that communities, advocates, and researchers have fought for decades to achieve.
[link removed]
** See AVAC’s r ([link removed]) esources tracking the impacts ([link removed]) and consequences of actions to dismantle foreign aid.
------------------------------------------------------------
New research on the HIV prevention pipeline is expected to be shared alongside evidence on how the dismantling of foreign aid and the retreat from US commitments to science and global health are impacting lives and livelihoods. Every aspect of the HIV response is under attack — from basic research and clinical development to policy, programs, and global access to life-saving treatment and prevention.
See AVAC’s new report ([link removed]) , which lays out what’s needed at this critical time to get HIV prevention into the hands of those that need it most, and join us Monday, July 14 for a satellite session, Re-imagining prevention: Ensuring sustainable PrEP access in an evolving funding context ([link removed]) .
[link removed]
IAS 2025 Resources
Use AVAC’s Roadmap ([link removed]) to find sessions where prevention and the larger issues of global health equity and sustainability are in the spotlight. You can download it as a sortable spreadsheet ([link removed]) or PDF ([link removed]) .
Follow events in real time. AVAC will offer comments and updates on Bluesky ([link removed]) , and our friends at NAM/aidsmap ([link removed]) and at Bhekisisa ([link removed]) will be reporting throughout the conference. Join the conversation using the conference hashtag #IAS2025 ([link removed]) .
Select Satellites, Sessions and Panels featuring AVAC and Partners
(All times listed are local in Kigali, Rwanda. See the time zone converter here ([link removed]) .)
Sunday, July 13
* Expanding PrEP Access: The Role of HIVST in Uptake and Scale-Up - HIV Self-Testing impact on HIV diagnosis and treatment ([link removed]) , Preconference, 09:00 – 12:45
* Building resilience: Strengthening national leadership, integration, and sustainable HIV programs in an era of funding transition - Sustaining HIV Prevention and Introducing / Scaling Long-Acting Prevention Tools: Navigating a Way Forward in the Current Environment ([link removed]) , Preconference, 14:00 – 17:45
Monday, July 14
* Re-imagining prevention: Planning for sustainable PrEP access in the new funding context ([link removed]) , Satellite, 09:30 - 11:00, sponsored by AVAC and the Ministry of Health of Zambia
* Consolidating and advancing African leadership of HIV Cure strategies to accelerate cure research for Africa and the world ([link removed]) , Satellite, 11:30 - 12:30
* The future of person-centred HIV prevention: Latest evidence from the African continent ([link removed]) , Satellite, 11:30 - 12:30
* What's new in WHO guidelines: Advancing prevention, testing, and treatment for impact and sustainability ([link removed]) , Satellite, 13:00 - 14:30, including the launch of new LEN for PrEP ([link removed]) guidelines
* Towards the finish line: Leveraging science to accelerate progress, sustain impact, and shape the future of HIV ([link removed]) , Satellite, 15:00 - 16:30
* 2025: Time to bring HIV, sexual and reproductive health together for better care ([link removed]) , Satellite, 15:00 - 16:30
Tuesday, July 15
* From PrEP to harm reduction: Scaling up comprehensive HIV prevention strategies ([link removed]) , Oral abstract, 10:45 - 11:45
* How Long-Acting Drugs Can Help End the HIV Pandemic in Africa ([link removed]) , Sponsor satellite, 12:15 - 13:15
* Confronting the storm: The future of the HIV response ([link removed]) , Special session, 13:30 - 14:45
* No retreat, no surrender: Sustaining the HIV response in times of turmoil ([link removed]) , Oral abstract, 15:00 - 16:00, featuring AVAC’s Richard Muko presenting about COMPASS’s comparative analysis of country policies and practices on domestic resource mobilization
* Health equity in challenging times: Threats and opportunities ([link removed]) , Oral abstract, 16:30 - 17:30, moderated by AVAC’s Mitchell Warren
* Harnessing the private sector to deliver HIV prevention ([link removed]) , Sponsor satellite, 18:00 - 19:30, featuring AVAC’s Catherine Verde Hashim presenting on policy shifts needed to deliver HIV prevention through the private sector
* The future of HIV prevention clinical trials ([link removed]) , Satellite, 18:00 - 19:30, featuring AVAC’s Grace Kumwenda presenting on community perspectives in HIV prevention clinical research
Wednesday, July 16
* Implementation of long-acting PrEP in real world settings - the ImPrEP Project ([link removed]) , Satellite, 12:15 - 13:15
* Co-Chair's choice ([link removed]) , Oral abstract, 15:00 - 16:00, featuring a presentation of the Phase 2 safety and pharmacokinetic study of MK-8527 as once-monthly oral PrEP
* Let’s get real: Implementing PrEP choice in practice ([link removed]) , Symposium, 15:00 - 16:00
* Developing objective targets for monitoring PrEP program progress ([link removed]) , Satellite, 18:00 - 19:30
Thursday, July 17
* Getting to grips with prevention ([link removed]) , Plenary, 09:00 - 10:30, featuring updates on HIV vaccine discovery medicine and evidence-based innovations to simplify and de-medicalize PrEP choice
* Purposeful PrEP: New insights on lenacapavir for prevention ([link removed]) , Oral abstract, 10:45 - 11:45
* Big money and the big picture: Funding and HIV epidemiology ([link removed]) , Oral abstract, 12:15 - 13:15, featuring an AVAC presentation on how policies influenced PrEP uptake
* Pregnancy and long-acting ARVs for prevention and treatment ([link removed]) , Symposium, 13:45 - 14:45, featuring AVAC partner Chilufya Kasanda of Ascend Futures Foundation in Zambia and updates from Merck, ViiV and Gilead on their respective PrEP programs
Access these resources, conference highlights and more at AVAC’s dedicated IAS 2025 page ([link removed]) . And watch this space for further updates.
Best,
AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed])
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
